(May 2020) Thomas Flaig, MD, professor of medicine in the Division of Medical Oncology, has been named vice chancellor of research for the University of Colorado Denver | Anschutz Medical Campus, effective March 1.
Flaig has been serving as interim vice chancellor since August 2019 and prior to that he had been associate dean for clinical research for the School of Medicine and chief clinical research officer for UCHealth.
In those roles, Flaig led the efforts to improve the clinical trials process and coordinate the research activities between the University and our clinical partners on the Anschutz Medical Campus. His efforts have helped lead to an improved web-based searchable database that researchers, clinicians, and patients can use to find clinical trials conducted by CU faculty.
Flaig also has led local and national multi-center clinical trials. He is a member of the National Cancer Institute’s Investigational Drug Steering Committee and the bladder cancer task force. He also serves as chair of the bladder cancer committee for the National Comprehensive Care Network, which publishes internationally recognized treatment guidelines, updated regularly with new research findings. He has active translational research collaborations with colleagues in the School of Medicine, School
of Pharmacy and the CU Boulder campus.